FORMULATION AND USE AGREEMENTFormulation and Use Agreement • February 11th, 2015 • Urigen Pharmaceuticals, Inc. • Pharmaceutical preparations • California
Contract Type FiledFebruary 11th, 2015 Company Industry JurisdictionThis Formulation and Use Agreement (the “Agreement”) is made and entered into as of [ ] (the “Effective Date”), by and between Urigen Pharmaceuticals, Inc., a Delaware corporation, having its principal office at 1700 North Broadway, Suite 330, Walnut Creek, CA 94596 (“URIGEN”), and [ ], a compounding pharmacy having its principal office at [ ] (“PHARMACY”). URIGEN and PHARMACY are sometimes each hereinafter referred to as a "Party" or collectively as "Parties" to this Agreement.